Multiple Sclerosis Disease‐Modifying Therapies in the COVID‐19 Era-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Multiple Sclerosis Disease‐Modifying Therapies in the COVID‐19 Era

Published:2020-09-30 Issue:6 Volume:88 Page:1062-1064
ISSN:0364-5134
Container-title:Annals of Neurology
language:en
Short-container-title:Ann Neurol

Author:

Ciotti John R.¹^ORCID,Grebenciucova Elena²,Moss Brandon P.³,Newsome Scott D.⁴

Affiliation:

1. Washington University School of Medicine St. Louis MO USA

2. Northwestern University Feinberg School of Medicine Chicago IL USA

3. Cleveland Clinic Mellen Center for MS Cleveland OH USA

4. Johns Hopkins University School of Medicine Baltimore MD USA

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ana.25907

Reference6 articles.

1. COViMS Registry.The COViMS Database Public Data Update.www.COViMS.org. Accessed September 1 2020.

2. Clinical characteristics and outcomes in patients with coronavirus disease 2019 and multiple sclerosis;Louapre C;JAMA Neurol,2020

3. An Italian programme for COVID-19 infection in multiple sclerosis

4. Multiple sclerosis management during the COVID‐19 pandemic;Moss BP;Mult Scler,2020

5. Effect of ocrelizumab on vaccine responses in patients with multiple sclerosis: the VELOCE study;Bar‐Or A;Neurology,2020

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Era of COVID-19 in Multiple Sclerosis Care;Neurologic Clinics;2024-02

2. Association between disease-modifying therapies and adverse clinical outcomes in multiple sclerosis patients with COVID-19 infection;Multiple Sclerosis and Related Disorders;2022-11

3. COVID-19 severity and outcome in multiple sclerosis: Results of a national, registry-based, matched cohort study;Multiple Sclerosis and Related Disorders;2021-10

4. Understanding and managing the impact of the Covid-19 pandemic and lockdown on patients with multiple sclerosis;Expert Review of Neurotherapeutics;2021-07-03

5. Neurological manifestations of COVID-19 in confirmed and probable cases: A descriptive study from a large tertiary care center;Journal of Clinical Neuroscience;2021-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3